The low-dose (1 μg) Cosyntropin Test (LDT) for Primary Adrenocortical Insufficiency: Defining the Normal Cortisol Response and Report on First Patients with Addison Disease Confirmed with LDT

 

 Buy Article Permissions and Reprints

Abstract

Background: The validity of low-dose 1 μg cosyntropin test (LDT) is reported mainly for the assessment of secondary adrenocortical insufficiency (AI). Likewise the hypothalamic-pituitary disorders, early diagnosis of the initial or partial stages of primary AI has an important role.

Objective: The aim of study was to: 1) establish the normal cut-off level at which the stimulated plasma cortisol (FP) in LDT excludes primary AI; 2) compare the results in elderly subjects to those in younger ones; 3) compare the results between normal and obese subjects; and 4) verify the established cut-off values on the sample of patients suspected to have primary AI.

Subjects and Methods: 110 subjects (99 women and 11 men, aged 19–80 years, mean 46.2±16.1 years, without suspicion for impairment of the hypothalamo-pituitary-adrenal axis were recruited to undergo the LDT in standard conditions. Control group consists of 30 patients (22 women and 8 men, aged 7–58 years, mean 38.4±10.6 years) evaluated in whom for suspicion of primary AI as suggested by LDT was confirmed by supplemental investigations (elevated ACTH levels, positive autoantibodies against 21-hydroxylase, mutational analysis of corresponding genes).

Results: The mean peak FP level at 30 min (FP₃₀) of the subjects was 675±85 nmol/L (95% CI=659 to 691 nmol/L), thus reference values expressed as mean±2 SD were 505–845 nmol/L. There was a significant negative correlation between basal FP values (FP₀) (434±105 nmol/L) and the absolute FP incremental (FP_Δ) response varying from 52 to 553 nmol/L (median 230 nmol/L) (r=–0.71; P<0.001). FP₃₀ was higher in elderly subjects (n=27) in comparison to younger subjects (n=25) (689±88 nmol/L vs. 642±63 nmol/L, u=2.11, P<0.05) due to higher FP_Δ (274±116 nmol/L vs. 175±112 nmol/L; u=4.02, P<0.01) ; FP₃₀ levels in obese subjects (n=27) did not differ from those with normal BMI (n=33) (694±100 nmol/L vs. 667±65 nmol/L, u=1.31, P>0.05). We did not find any correlation between body weight or body surface area and FP₀, FP₃₀ or FP_Δ. Post-stimulation FP₃₀ levels in the control group varied from 0 to 354 nmol/L with median 64 nmol/L (25^th percentile 10 nmol/L; 75^th percentile 165 nmol/L) and were entirely distinctive from those of the subjects without adrenal impairment (P<0.001).

Conclusions: Taking the mean –2 SD result as a threshold, FP value of 500 nmol/L can be consider as cut-off at 30 min in the LDT for defining the intact adrenocortical function, independently of age and body weight, body surface area.

References

• 1 Abdu T, Elhadd T, Neary R. et al . Comparison of the low dose short synacthen test (1 μg), the conventional dose short synacthen test (250 μg), and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease.  J Clin Endocrinol Metab. 1998;  84 838-843
  PubMedGoogle Scholar
• 2 Annane D, Bellissant E, Bollaert PE. et al . Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.  BMJ. 2004;  329 480
  CrossrefPubMedGoogle Scholar
• 3 Azziz R, Fox LM, Zacur HA. et al . Adrenocortical secretion of dehydroepiandrosterone in healthy women: highly variable response to adrenocorticotropin.  J Clin Endocrinol Metab. 2001;  86 2513-2517
  CrossrefPubMedGoogle Scholar
• 4 Beishuizen A, Thijs LG, Haanen C. et al . Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness.  J Clin Endocrinol Metab. 2001;  86 2811-2816
  CrossrefPubMedGoogle Scholar
• 5 Born J, Ditschuneit I, Schreiber M. et al . Effect of age and gender on pituitary-adrenocortical responsiveness in humans.  Eur J Endocrinol. 1995;  132 705-711
  CrossrefPubMedGoogle Scholar
• 6 Boscarbo M, Betterle C, Sonino N. et al . Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency.  J Clin Endocrinol Metab. 1994;  79 452-455
  CrossrefPubMedGoogle Scholar
• 7 Broide J, Soferman R, Kivity S. et al . Low-dose adrenocorticotropin test reveals impaired adrenal function in patients taking inhaled corticosteroids.  J Clin Endocrinol Metab. 1995;  80 1243-1246
  CrossrefPubMedGoogle Scholar
• 8 Carey RM. The changing clinical spectrum of adrenal insufficiency.  Ann Int Med. 1997;  127 1103-1105
  PubMedGoogle Scholar
• 9 Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients.  N Engl J Med. 2003;  348 727-734
  CrossrefPubMedGoogle Scholar
• 10 Dickstein G, Schechner C, Nicholson WE. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test.  J Clin Endocrinol Metab. 1991;  80 1243-1246
  PubMedGoogle Scholar
• 11 Dickstein G, Spigel D, Arad E. et al . One microgram is the lowest ACTH dose to cause maximal cortisol response. There is no diurnal variation of cortisol response to submaximal ACTH stimulation.  Eur J Endocrinol. 1997;  137 172-175
  CrossrefPubMedGoogle Scholar
• 12 Dickstein G. The low dose (1 μg) ACTH test: when and how to use it.  Clin Endocrinol (Oxf). 1998;  49 135
  CrossrefPubMedGoogle Scholar
• 13 Dorin RI, Qualls CR, Crapo LM. Diagnosis of adrenal insufficiency.  Ann Intern Med. 2003;  139 194-204
  PubMedGoogle Scholar
• 14 el-Deiry SS, Naidu S, Blevins LS. et al . Assessment of adrenal function in women heterozygous for adrenoleukodystrophy.  J Clin Endocrinol Metab. 1997;  82 856-860
  CrossrefPubMedGoogle Scholar
• 15 Findling JW, Buggy BP, Glison IH. et al . Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus.  J Clin Endocrinol Metab. 1994;  79 1091-1096
  CrossrefPubMedGoogle Scholar
• 16 Giordano R, Di Vito L, Lanfranco F. et al . Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH_1–24.  Clin Endocrinol (Oxf). 2001;  55 259-265
  CrossrefPubMedGoogle Scholar
• 17 Gonzálbez J, Villabona C, Ramón J. et al . Establishement of reference values for standard dose short synacthen test (250 ug), low dose short synacthen test (1 μg) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects.  Clin Endocrinol (Oxf). 2000;  53 199-204
  CrossrefPubMedGoogle Scholar
• 18 González-González JG, De la Garza-Hernandez NE, Mancillas-Adame LG. et al . A high-sensitivity test in the assessment of adrenocortical insufficiency: 10 microg vs 250 microg cosyntropin dose assessment of adrenocortical insufficiency.  J Endocrinol. 1998;  159 275-280
  CrossrefPubMedGoogle Scholar
• 19 Grinspoon SK, Biller BMK. Clinical review 62: laboratory assessment of adrenal insufficiency.  J Clin Endocrinol Metab. 1994;  79 923-931
  CrossrefPubMedGoogle Scholar
• 20 Ketchum CH, Riley WJ, Maclaren NK. Adrenal dysfunction in asymptomatic patients with adrenocortical autoantibodies.  J Clin Endocrinol Metab. 1984;  58 1166-1170
  CrossrefPubMedGoogle Scholar
• 21 Laureti S, Arvat E, Candeloro P. et al . Low dose (1 ug) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease.  Clin Endocrinol (Oxf). 2000;  53 107-115
  CrossrefPubMedGoogle Scholar
• 22 Laureti S, Candeloro P, Aglietti MC. et al . DHEA, 17alpha-hydroxyprogesterone and aldosterone responses to the low dose (1 ug) ACTH test in subjects with pre-clinical adrenal autoimmunity.  Clin Endocrinol (Oxf). 2002;  57 677-683
  CrossrefPubMedGoogle Scholar
• 23 Maccario M, Grottoli S, Di Vito L. et al . Adrenal responsiveness to high, low and very low ACTH 1–24 doses in obesity.  Clin Endocrinol (Oxf). 2000;  53 437-444
  CrossrefPubMedGoogle Scholar
• 24 Magitta NF, Pura M, Bøe Wolff AS. et al . Autoimmune polyendocrine syndrome type I in Slovakia: relevance of screening patients with autoimmune Addison's disease.  Eur J Endocrinol. 2008;  158 705-709
  CrossrefPubMedGoogle Scholar
• 25 Marcus-Perlman Z, Tordjman K, Greenman Y. et al . Low-dose ACTH (1 ug) test: a potential alternative to the classical blood test.  Clin Endocrinol (Oxf). 2006;  64 215-218
  CrossrefPubMedGoogle Scholar
• 26 Marik PE, Zaloga GP. Adrenal insufficiency in the critically ill: a new look at an old problem.  Chest. 2002;  122 1784-1796
  CrossrefPubMedGoogle Scholar
• 27 Mayenknecht J, Diederich S, Bahr V. et al . Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.  J Clin Endocrinol Metab. 1998;  83 1558-1562
  CrossrefPubMedGoogle Scholar
• 28 Miller WL. P450 oxidoreductase deficiency: a new disorder of steroidogenesis with multiple clinical manifestations.  Trends Endocrinol Metab. 2004;  15 311-315
  CrossrefPubMedGoogle Scholar
• 29 Oelkers W, Diederich S, Bahr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.  J Clin Endocrinol Metab. 1992;  75 259-264
  CrossrefPubMedGoogle Scholar
• 30 Oki K, Yamane K, Yoneda M. et al . A case of Addison's disease confirmed with low dose cosyntropin stimulation test.  Endocrine J. 2007;  54 765-769
  CrossrefPubMedGoogle Scholar
• 31 Orth DN, Kovacs WJ. Tests for evaluating primary and secundary adrenal insufficiency. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR, eds. Williams textbook of endocrinology. 9th edn Philadelphia: WB Saunders Co 1998: 618
  Google Scholar
• 32 Parker CR, Slayden SM, Azziz R. et al . Effects of aging on adrenal function in the human: responsiveness and sensitivity of adrenal androgens and cortisol to adrenocorticotropin in premenopausal and postmenopausal women.  J Clin Endocrinol Metab. 2000;  85 48-54
  CrossrefPubMedGoogle Scholar
• 33 Patel L, Clayton PE. Clinical usefulness of the low dose ACTH test.  J Endocrinol Invest. 1999;  22 401-404
  PubMedGoogle Scholar
• 34 Rasmuson S, Olsson T, Hägg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis.  Clin Endocrinol (Oxf). 1996;  44 151-156
  CrossrefPubMedGoogle Scholar
• 35 Seeman TE, Robbins RJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans.  Endocrin Rev. 1994;  15 233-260
  CrossrefPubMedGoogle Scholar
• 36 Šimůnková K, Hampl R, Hill M. et al . Salivary cortisol in low dose (1 μg) ACTH test in healthy women: comparison with serum cortisol.  Physiol Res. 2007;  56 449-453
  PubMedGoogle Scholar
• 37 Smolyar D, Tirado-Bernardini R, Landman R. et al . Comparison of 1-micro g and 250-micro g corticotropin stimulation tests for the evaluation of adrenal function in patients with acquired immunodeficiency syndrome.  Metabolism. 2003;  52 647-651
  CrossrefPubMedGoogle Scholar
• 38 Streeten DHP. Shortcomings in the low-dose (1 μg) ACTH test for the diagnosis of ACTH deficiency states (editorial).  J Clin Endocrinol Metab. 1999;  84 835-837
  CrossrefPubMedGoogle Scholar
• 39 Thaler LM, Blevins  Jr  LS. The low dose (1-μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency.  J Clin Endocrinol Metab. 1998;  83 2726-2729
  CrossrefPubMedGoogle Scholar
• 40 Tordjman K, Jaffe A, Grazas N. et al . The role of the low dose (1 μg) adrenocorticotropin test in the evaluation of patients with pituitary diseases.  J Clin Endocrinol Metab. 1995;  80 1301-1305
  CrossrefPubMedGoogle Scholar
• 41 Wang PS, Lo MJ, Kau MM. Glucocorticoids and aging.  J Form Med Assoc. 1997;  96 792-801
  PubMedGoogle Scholar
• 42 Wilkinson CW, Peskind ER, Raskind MA. Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.  Neuroendocrinol. 1997;  65 79-90
  CrossrefPubMedGoogle Scholar
• 43 Yeung MY. Adrenal insufficiency as the underlying cause of skewed cytokine profile in low gestation newborns.  World J Pediatr. 2006;  2 90-96
  PubMedGoogle Scholar

Correspondence

M. PuraMD 

Department of Endocrinology

National Institute of Endocrinology and Diabetology

034 91 Lubochna

Slovakia

Phone: +421/44/4306 113 214

Fax: +421/44/4306 322

Email: mikulas.pura@nedu.sk